Therefore, the role of bradykinin in the pathogenesis of microvascular dysfunction in COVID-19 is questionable and more likely a result of the effects of Ang II, stemming from a downregulation of ACE2 after viral entry into cells. This evidence concerns the gene ACE2 and COVID-19.